Compare FENG & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENG | XCUR |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 26.6M |
| IPO Year | 2011 | N/A |
| Metric | FENG | XCUR |
|---|---|---|
| Price | $1.77 | $4.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.0K | ★ 48.0K |
| Earning Date | 03-10-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $106,947,410.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.17 | N/A |
| 52 Week Low | $1.28 | $3.10 |
| 52 Week High | $3.65 | $15.91 |
| Indicator | FENG | XCUR |
|---|---|---|
| Relative Strength Index (RSI) | 40.40 | 37.88 |
| Support Level | $1.75 | $3.82 |
| Resistance Level | $1.82 | $4.40 |
| Average True Range (ATR) | 0.04 | 0.40 |
| MACD | -0.00 | -0.11 |
| Stochastic Oscillator | 15.75 | 15.96 |
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.